QQQ   438.07 (+2.93%)
AAPL   184.37 (+1.12%)
MSFT   411.65 (+2.35%)
META   486.13 (+3.87%)
GOOGL   144.09 (+1.08%)
AMZN   174.58 (+3.55%)
TSLA   197.41 (+1.36%)
NVDA   785.38 (+16.40%)
NIO   5.85 (-2.01%)
AMD   181.86 (+10.69%)
BABA   76.12 (+0.70%)
T   16.59 (-2.41%)
F   12.12 (-0.16%)
MU   85.91 (+5.42%)
CGC   3.37 (-2.03%)
GE   151.67 (+1.74%)
DIS   107.63 (-0.04%)
AMC   4.42 (-3.28%)
PFE   27.55 (-0.43%)
PYPL   58.35 (+1.51%)
XOM   104.76 (-0.09%)
QQQ   438.07 (+2.93%)
AAPL   184.37 (+1.12%)
MSFT   411.65 (+2.35%)
META   486.13 (+3.87%)
GOOGL   144.09 (+1.08%)
AMZN   174.58 (+3.55%)
TSLA   197.41 (+1.36%)
NVDA   785.38 (+16.40%)
NIO   5.85 (-2.01%)
AMD   181.86 (+10.69%)
BABA   76.12 (+0.70%)
T   16.59 (-2.41%)
F   12.12 (-0.16%)
MU   85.91 (+5.42%)
CGC   3.37 (-2.03%)
GE   151.67 (+1.74%)
DIS   107.63 (-0.04%)
AMC   4.42 (-3.28%)
PFE   27.55 (-0.43%)
PYPL   58.35 (+1.51%)
XOM   104.76 (-0.09%)
QQQ   438.07 (+2.93%)
AAPL   184.37 (+1.12%)
MSFT   411.65 (+2.35%)
META   486.13 (+3.87%)
GOOGL   144.09 (+1.08%)
AMZN   174.58 (+3.55%)
TSLA   197.41 (+1.36%)
NVDA   785.38 (+16.40%)
NIO   5.85 (-2.01%)
AMD   181.86 (+10.69%)
BABA   76.12 (+0.70%)
T   16.59 (-2.41%)
F   12.12 (-0.16%)
MU   85.91 (+5.42%)
CGC   3.37 (-2.03%)
GE   151.67 (+1.74%)
DIS   107.63 (-0.04%)
AMC   4.42 (-3.28%)
PFE   27.55 (-0.43%)
PYPL   58.35 (+1.51%)
XOM   104.76 (-0.09%)
QQQ   438.07 (+2.93%)
AAPL   184.37 (+1.12%)
MSFT   411.65 (+2.35%)
META   486.13 (+3.87%)
GOOGL   144.09 (+1.08%)
AMZN   174.58 (+3.55%)
TSLA   197.41 (+1.36%)
NVDA   785.38 (+16.40%)
NIO   5.85 (-2.01%)
AMD   181.86 (+10.69%)
BABA   76.12 (+0.70%)
T   16.59 (-2.41%)
F   12.12 (-0.16%)
MU   85.91 (+5.42%)
CGC   3.37 (-2.03%)
GE   151.67 (+1.74%)
DIS   107.63 (-0.04%)
AMC   4.42 (-3.28%)
PFE   27.55 (-0.43%)
PYPL   58.35 (+1.51%)
XOM   104.76 (-0.09%)
NASDAQ:NTRB

Nutriband (NTRB) Stock Price, News & Analysis

$2.49
+0.05 (+2.05%)
(As of 02/22/2024 ET)
Today's Range
$2.41
$2.65
50-Day Range
$2.32
$3.05
52-Week Range
$1.53
$5.15
Volume
2,567 shs
Average Volume
7,960 shs
Market Capitalization
$19.50 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

NTRB stock logo

About Nutriband Stock (NASDAQ:NTRB)

Nutriband Inc. develops a portfolio of transdermal pharmaceutical products. Its lead product in development is AVERSA fentanyl, an abuse deterrent fentanyl transdermal system that provides clinicians and patients with an extended-release transdermal fentanyl product for use in managing chronic pain requiring around the clock opioid therapy. The company also develops other products, which include AVERSA buprenorphine and AVERSA methylphenidate; exenatide for type 2 diabetes; and follicle stimulating hormone for infertility. It has a license agreement with Rambam Med-Tech Ltd. for the development of the RAMBAM Closed System Transfer Devices; and Kindeva Drug Delivery, L.P. to develop AVERSAL Fentanyl based on its proprietary AVERSAL abuse deterrent transdermal technology. The company was incorporated in 2016 and is headquartered in Orlando, Florida.

NTRB Stock Price History

NTRB Stock News Headlines

Nutriband (NASDAQ:NTRB) Trading Down 5.9%
AI Stock Caught Trading Under Secret Name
We have uncovered perhaps the most unusual AI stock we've ever seen.It's expected to see massive revenue this year - $215 billion.  The company holds over 29,000 patents in the U.S. It pays an enormous dividend.
Nutriband CEO Publishes Letter to Shareholders
Nutriband Inc NTRB
AI Stock Caught Trading Under Secret Name
We have uncovered perhaps the most unusual AI stock we've ever seen.It's expected to see massive revenue this year - $215 billion.  The company holds over 29,000 patents in the U.S. It pays an enormous dividend.
See More Headlines
Receive NTRB Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Nutriband and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
12/12/2023
Today
2/22/2024
Next Earnings (Estimated)
4/24/2024
Fiscal Year End
1/31/2025

Industry, Sector and Symbol

Sector
Medical
Industry
Surgical appliances & supplies
Sub-Industry
N/A
Current Symbol
NASDAQ:NTRB
Fax
N/A
Employees
3
Year Founded
N/A

Profitability

Net Income
$-4,480,000.00
Net Margins
-252.90%
Pretax Margin
-252.90%

Debt

Sales & Book Value

Annual Sales
$2.08 million
Book Value
$1.09 per share

Miscellaneous

Free Float
4,453,000
Market Cap
$20.20 million
Optionable
Not Optionable
Beta
0.75
Elon Musk's Next Move Cover

Wondering when you'll finally be able to invest in SpaceX, StarLink, or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.

Get This Free Report

Key Executives

  • Mr. Serguei Melnik (Age 50)
    Founder, President, Company Secretary & Executive Chairman of the Board
    Comp: $200k
  • Mr. Gareth Sheridan (Age 34)
    Founder, CEO & Director
    Comp: $200k
  • Mr. Gerald Goodman (Age 76)
    CFO & Chief Accounting Officer
    Comp: $160k
  • Dr. Alan Smith Ph.D. (Age 58)
    COO & President of 4P Therapeutics
    Comp: $179k
  • Mr. Patrick Ryan (Age 38)
    Chief Technical Officer
  • Dr. Jeffrey Patrick Pharm.D. (Age 54)
    Chief Scientific Officer
  • Mr. Tyler Overk (Age 40)
    President of Active Intelligence














NTRB Stock Analysis - Frequently Asked Questions

How have NTRB shares performed in 2024?

Nutriband's stock was trading at $2.32 at the beginning of the year. Since then, NTRB shares have increased by 7.3% and is now trading at $2.49.
View the best growth stocks for 2024 here
.

Are investors shorting Nutriband?

Nutriband saw a decrease in short interest during the month of January. As of January 31st, there was short interest totaling 400 shares, a decrease of 91.8% from the January 15th total of 4,900 shares. Based on an average daily trading volume, of 7,900 shares, the days-to-cover ratio is presently 0.1 days. Currently, 0.0% of the company's shares are short sold.
View Nutriband's Short Interest
.

When is Nutriband's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, April 24th 2024.
View our NTRB earnings forecast
.

How were Nutriband's earnings last quarter?

Nutriband Inc. (NASDAQ:NTRB) posted its earnings results on Tuesday, December, 12th. The company reported ($0.22) earnings per share for the quarter. The business earned $0.43 million during the quarter. Nutriband had a negative trailing twelve-month return on equity of 73.13% and a negative net margin of 252.90%.

When did Nutriband's stock split?

Nutriband's stock split before market open on Monday, August 15th 2022. The 13-6 split was announced on Monday, August 15th 2022. The newly created shares were distributed to shareholders after the closing bell on Monday, August 15th 2022. An investor that had 100 shares of stock prior to the split would have 217 shares after the split.

Who are Nutriband's major shareholders?

Nutriband's stock is owned by a number of retail and institutional investors. Top institutional investors include AlphaQ Advisors LLC (0.15%).

How do I buy shares of Nutriband?

Shares of NTRB stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:NTRB) was last updated on 2/22/2024 by MarketBeat.com Staff